Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Budget Request Is Flat For Drugs, Pressuring Stakeholders

Executive Summary

Industry and advocates will have to take up fight for more CDER funding after Obama depends entirely on fees for human drugs program budget increase.

You may also be interested in...



Trump Budget Would Remove Tobacco From FDA, Increase Dependency On User Fees

Much of the 4.5% increase proposed would come from proposed new user fees; almost no new budget authority was allocated in President’s FY 2021 budget request.

US FDA Gets Another Appropriations Increase In FY 2020 House Bill

Overall percentage increase is not as high as the FY 2019 spending bill, but stakeholders are happy with the proposed boost in budget authority.

US FDA's China Staff Increase Takes Hold As Gottlieb Boosts Border Security

After receiving delayed visas, additional FDA is inspectors and other staff can relocate to China office; Gottlieb also announces increase in international mail facility staff.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS057450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel